Literature DB >> 16925946

Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc.

Mu-Shui Dai1, Yetao Jin, Jayme R Gallegos, Hua Lu.   

Abstract

Protein ubiquitylation has been demonstrated to play a vital role not only in mediating protein turnover but also in modulating protein activity. The stability and activity of the tumor suppressor p53 and of the oncoprotein c-Myc are no exception. Both are regulated through independent ubiquitylation by several E3 ubiquitin ligases. Interestingly, p53 and c-Myc are functionally connected by some of these E3 enzymes and their regulator ARF, although these proteins play opposite roles in controlling cell growth and proliferation. The balance of this complex ubiquitylation network and its disruption during oncogenesis will be the topics of this review.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16925946      PMCID: PMC1601943          DOI: 10.1593/neo.06334

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  245 in total

Review 1.  Transcriptional repression by Myc.

Authors:  Michael Wanzel; Steffi Herold; Martin Eilers
Journal:  Trends Cell Biol       Date:  2003-03       Impact factor: 20.808

2.  p53 has a direct apoptogenic role at the mitochondria.

Authors:  Motohiro Mihara; Susan Erster; Alexander Zaika; Oleksi Petrenko; Thomas Chittenden; Petr Pancoska; Ute M Moll
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

3.  Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

Authors:  Roger P Leng; Yunping Lin; Weili Ma; Hong Wu; Benedicte Lemmers; Stephen Chung; John M Parant; Guillermina Lozano; Razqallah Hakem; Samuel Benchimol
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

4.  Skp2 regulates Myc protein stability and activity.

Authors:  So Young Kim; Andreas Herbst; Kathryn A Tworkowski; Simone E Salghetti; William P Tansey
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

5.  Critical role for a central part of Mdm2 in the ubiquitylation of p53.

Authors:  Erik Meulmeester; Ruth Frenk; Robert Stad; Petra de Graaf; Jean-Christophe Marine; Karen H Vousden; Aart G Jochemsen
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

6.  Polyubiquitination of p53 by a ubiquitin ligase activity of p300.

Authors:  Steven R Grossman; Maria E Deato; Chrystelle Brignone; Ho Man Chan; Andrew L Kung; Hideaki Tagami; Yoshihiro Nakatani; David M Livingston
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

7.  Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.

Authors:  Eun-Hee Shim; Linda Johnson; Hye-Lim Noh; Yoon-Jung Kim; Hong Sun; Caroline Zeiss; Hui Zhang
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

Review 8.  Decision making by p53: life, death and cancer.

Authors:  M Oren
Journal:  Cell Death Differ       Date:  2003-04       Impact factor: 15.828

9.  The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription.

Authors:  Natalie von der Lehr; Sara Johansson; Siqin Wu; Fuad Bahram; Alina Castell; Cihan Cetinkaya; Per Hydbring; Ingrid Weidung; Keiko Nakayama; Keiichi I Nakayama; Ola Söderberg; Tom K Kerppola; Lars-Gunnar Larsson
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

10.  Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation.

Authors:  Krishna P Bhat; Koji Itahana; Aiwen Jin; Yanping Zhang
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

View more
  40 in total

1.  Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.

Authors:  Mikael S Lindström; Aiwen Jin; Chad Deisenroth; Gabrielle White Wolf; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2006-11-20       Impact factor: 4.272

2.  The contribution of transactivation subdomains 1 and 2 to p53-induced gene expression is heterogeneous but not subdomain-specific.

Authors:  Jennifer M Smith; Lawton J Stubbert; Jeffrey D Hamill; Bruce C McKay
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

Review 3.  Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1.

Authors:  Xiao-Xin Sun; Mu-Shui Dai
Journal:  World J Biol Chem       Date:  2014-05-26

4.  β-Catenin-dependent FGF signaling sustains cell survival in the anterior embryonic head by countering Smad4.

Authors:  Hunki Paek; Jee-Yeon Hwang; R Suzanne Zukin; Jean M Hébert
Journal:  Dev Cell       Date:  2011-05-17       Impact factor: 12.270

Review 5.  Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

Authors:  Tiffany Devine; Mu-Shui Dai
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

Review 7.  ROS and p53: a versatile partnership.

Authors:  Bin Liu; Yumin Chen; Daret K St Clair
Journal:  Free Radic Biol Med       Date:  2008-01-26       Impact factor: 7.376

8.  The real face of juvenile polyposis syndrome.

Authors:  Beatrix Tam; Agnes Salamon; Attila Bajtai; Annamária Németh; János Kiss; László Simon; Tamás Molnár
Journal:  J Gastrointest Oncol       Date:  2012-12

9.  Ribosomal protein S14 negatively regulates c-Myc activity.

Authors:  Xiang Zhou; Qian Hao; Jun-Ming Liao; Peng Liao; Hua Lu
Journal:  J Biol Chem       Date:  2013-06-17       Impact factor: 5.157

Review 10.  Signaling to p53: ribosomal proteins find their way.

Authors:  Yanping Zhang; Hua Lu
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.